In a mass spectrometry-based study [45], galectin 4, a group of carbohydrate-binding proteins involved in neoplastic development and progression, was identified as a down-regulated protein in short-term survivors of pancreatic cancer and correlated with an ER [46]. Here, LGALS4 is linked to pancreatic neoplasm.